4.7 Article

Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease

期刊

NEUROLOGY
卷 95, 期 10, 页码 E1301-E1311

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000010192

关键词

-

资金

  1. Miguel Servet program [CP19/00031]
  2. Spanish Instituto de Salud Carlos III (ISCIII-FEDER)

向作者/读者索取更多资源

Objective To study the neuropathologic correlates of cholinergic basal forebrain (BF) atrophy as determined using antemortem MRI in the Alzheimer disease (AD) spectrum. Methods We determined associations between BF volume from antemortem MRI brain scans and postmortem assessment of neuropathologic features, including neuritic plaques, neurofibrillary tangles (NFTs), Lewy body (LB) pathology, and TDP-43, in 64 cases of the Alzheimer's Disease Neuroimaging Initiative cohort. For comparison, we assessed neuropathologic features associated with hippocampal and parahippocampal gyrus atrophy. In addition to region of interest-based analysis, we determined the association of neuropathologic features with whole brain gray matter volume using regionally unbiased voxel-based volumetry. Results BF atrophy was associated with Thal amyloid phases (95% confidence interval [CI] -0.49 to -0.01,p= 0.049) and presence of LB pathology (95% CI -0.54 to -0.06,p= 0.015), as well as with the degree of LB pathology within the nucleus basalis Meynert (95% CI -0.54 to -0.07,p= 0.025). These effects were no longer significant after false discovery rate (FDR) correction. Hippocampal atrophy was significantly associated with the presence of TDP-43 pathology (95% CI -0.61 to -0.17,p= 0.003; surviving FDR correction), in addition to dentate gyrus NFT load (95% CI -0.49 to -0.01,p= 0.044; uncorrected). Voxel-based analysis confirmed spatially restricted effects of Thal phases and presence of LB pathology on BF volume. Conclusions These findings indicate that neuropathologic correlates of regional atrophy differ substantially between different brain regions that are typically involved in AD-related neurodegeneration, including different susceptibilities to common comorbid pathologies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Geriatrics & Gerontology

Comparison of behaviors characteristic of autism spectrum disorder behaviors and behavioral and psychiatric symptoms of dementia

Elizabeth K. Rhodus, Justin Barber, Erin L. Abner, Shoshana H. Bardach, Allison Gibson, Gregory A. Jicha

Summary: There is significant overlap in behaviors characteristic of ASD and BPSD in adults with ADRD, suggesting a need for further research into causes and therapeutic approaches.

AGING & MENTAL HEALTH (2022)

Article Clinical Neurology

Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort

Zachary Winder, Tiffany L. Sudduth, Sonya Anderson, Ela Patel, Janna Neltner, Barbara J. Martin, Katherine E. Snyder, Erin L. Abner, Gregory A. Jicha, Peter T. Nelson, Donna M. Wilcock

Summary: The study evaluated the relationship between plasma biomarkers and neuropathology associated with Alzheimer's disease (AD) and vascular contributions to cognitive impairment and dementia (VCID). The results showed certain plasma biomarkers were associated with AD and VCID pathology, providing support for further research in using plasma biomarkers as a clinical screening tool.

ALZHEIMERS & DEMENTIA (2023)

Article Geriatrics & Gerontology

Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

Jiehui Jiang, Can Sheng, Guanqun Chen, Chunhua Liu, Shichen Jin, Lanlan Li, Xueyan Jiang, Ying Han

Summary: Exploring individual hallmarks of brain ageing is important. In this study, the age-related glucose metabolism pattern (ARGMP) is proposed as a potential index to characterize brain ageing in cognitively normal elderly individuals and predict high conversion risk into cognitive impairment.

GEROSCIENCE (2022)

Article Clinical Neurology

Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC

Michel J. Grothe, Alexis Moscoso, Jesus Silva-Rodriguez, Catharina Lange, Kwangsik Nho, Andrew J. Saykin, Peter T. Nelson, Michael Scholl, Ralph Buchert, Stefan Teipel

Summary: This study investigated the clinical utility of an autopsy-derived FDG-PET signature for differential diagnosis of amnestic dementia patients. The study found that an FDG-PET pattern resembling LATE-NC can identify older patients with clinical features consistent with underlying LATE-NC. These patients exhibit a memory-predominant profile and a slower disease course.

ALZHEIMERS & DEMENTIA (2023)

Article Neurosciences

Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity

Doaa G. Ali, Ahmed A. Bahrani, Justin M. Barber, Riham H. El Khouli, Brian T. Gold, Jordan P. Harp, Yang Jiang, Donna M. Wilcock, Gregory A. Jicha

Summary: This study found that early focal regional amyloid deposition in the brain is associated with changes in executive function, but not memory, in preclinical Alzheimer's disease (pAD).

JOURNAL OF ALZHEIMERS DISEASE (2022)

Article Biology

Aβ efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas

Nirmal Verma, Gopal Viswanathan Velmurugan, Edric Winford, Han Coburn, Deepak Kotiya, Noah Leibold, Laura Radulescu, Sanda Despa, Kuey C. Chen, Linda J. Van Eldik, Peter T. Nelson, Donna M. Wilcock, Gregory A. Jicha, Ann M. Stowe, Larry B. Goldstein, David K. Powel, Jeffrey H. Walton, Manuel F. Navedo, Matthew A. Nystoriak, Andrew J. Murray, Geert Jan Biessels, Claire Troakes, Henrik Zetterberg, John Hardy, Tammaryn Lashley, Florin Despa

Summary: Impairment of vascular pathways contributes to Alzheimer's disease. Blood amylin secreted from the pancreas perturbs cerebral A beta clearance, leading to amylin and A beta co-deposits in the brain microvasculature. Altering bloodborne amylin could potentially reduce cerebrovascular amylin deposits and A beta pathology.

COMMUNICATIONS BIOLOGY (2023)

Editorial Material Clinical Neurology

Towards in vivo PET imaging of primary age-related tauopathy

Joseph Therriault, Michel J. Grothe

Article Clinical Neurology

Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies

Niels Okkels, Jacob Horsager, Miguel Labrador-Espinosa, Pernille L. Kjeldsen, Malene F. Damholdt, Janne Mortensen, Karsten Vestergard, Karoline Knudsen, Katrine B. Andersen, Tatyana D. Fedorova, Casper Skjaerbaek, Hanne Gottrup, Allan K. Hansen, Michel J. Grothe, Per Borghammer

Summary: Cholinergic changes are highly relevant in the progression of dementia with Lewy bodies. This study found significant loss of cholinergic terminals in newly diagnosed patients with dementia with Lewy bodies, which correlated with atrophy of cholinergic cell clusters in the basal forebrain. The study also suggests that cholinergic system degeneration is linked with brain metabolism and degeneration of other neurotransmitter systems.
Article Clinical Neurology

Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease

Laura Munoz-Delgado, Miguel Angel Labrador-Espinosa, Daniel Macias-Garcia, Silvia Jesus, Belen Benitez Zamora, Paula Fernandez-Rodriguez, Astrid D. Adarmes-Gomez, Maria Isabel Reina Castillo, Sandra Castro-Labrador, Jesus Silva-Rodriguez, Fatima Carrillo, David Garcia Solis, Michel J. Grothe, Pablo Mir

Summary: Two independent studies found that peripheral immune responses are associated with dopaminergic degeneration in Parkinson's disease (PD), with a main correlation found with lymphocyte count.

MOVEMENT DISORDERS (2023)

Article Computer Science, Artificial Intelligence

ADCoC: Adaptive Distribution Modeling Based Collaborative Clustering for Disentangling Disease Heterogeneity from Neuroimaging Data

Hangfan Liu, Michel J. Grothe, Tanweer Rashid, Miguel A. Labrador-Espinosa, Jon B. Toledo, Mohamad Habes

Summary: In this paper, a method is proposed to improve clustering of subjects in neuroimaging applications by exploiting the underlying clusters of features and suppressing noise through nonnegative matrix tri-factorization and adaptive regularization. Experimental results on synthetic data and real magnetic resonance imaging (MRI) data demonstrate the superiority of the proposed method.

IEEE TRANSACTIONS ON EMERGING TOPICS IN COMPUTATIONAL INTELLIGENCE (2023)

Article Clinical Neurology

Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease

Julia Schumacher, Prabesh Kanel, Martin Dyrba, Alexander Storch, Nicolaas Bohnen, Stefan Teipel, Michel J. Grothe

Summary: The study aimed to investigate the relationship between basal forebrain degeneration and cortical acetylcholinesterase activity in Parkinson’s disease, as well as their contribution to cognitive impairment. The findings demonstrated that the hypo-cholinergic Parkinson’s group had significantly reduced posterior basal forebrain volume compared to both the normo-cholinergic Parkinson’s group and the control group. Furthermore, the volume of posterior basal forebrain was significantly associated with cortical acetylcholinesterase activity in Parkinson’s patients, and both cholinergic markers were independently associated with multi-domain cognitive deficits.
Review Clinical Neurology

A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia

Atri Chatterjee, Veronica Hirsch-Reinshagen, Imogene Scott, Neil Cashman, Ging-Yuek Robin Hsiung

Summary: This study conducted a systematic review and found that the frequency of psychosis in FTD patients was 24.2%. Among the genetic mutation carriers, C9orf72 mutation carriers had the highest frequency of psychosis (31.4%), while GRN and MAPT mutation carriers had lower frequencies of psychosis. Among the pathological subtypes, patients with FUS pathology, TDP-43 pathology, and tau pathology had a prevalence of psychosis at 30%, 25.3%, and 16.4% respectively.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Psychiatry

Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia Spectrum

Julia Schulz, Felix Brandl, Michel J. Grothe, Matthias Kirschner, Stefan Kaiser, Andre Schmidt, Stefan Borgwardt, Josef Priller, Christian Sorg, Mihai Avram

Summary: This study used VBM technology and different stages of schizophrenia patients to find that the volumes of basal-forebrain cholinergic nuclei were smaller in patients with schizophrenia and were correlated with attentional deficits. However, it is unclear if and how these changes and their link to cognitive symptoms extend across the schizophrenia spectrum.

SCHIZOPHRENIA BULLETIN (2023)

Article Clinical Neurology

Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease

Laura Munoz-Delgado, Miguel Angel Labrador-Espinosa, Daniel Macias-Garcia, Silvia Jesus, Belen Benitez Zamora, Paula Fernandez-Rodriguez, Astrid D. Adarmes-Gomez, Maria Isabel Reina Castillo, Sandra Castro-Labrador, Jesus Silva-Rodriguez, Fatima Carrillo, David Garcia Solis, Michel J. Grothe, Pablo Mir

Summary: The findings from two independent cohorts suggest a relationship between systemic inflammation and dopaminergic degeneration in patients with PD, primarily driven by lymphocyte count.

MOVEMENT DISORDERS (2023)

Article Cell Biology

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease

Yuanbing Jiang, Xiaopu Zhou, Hiu Yi Wong, Li Ouyang, Fanny C. F. Ip, Vicky M. N. Chau, Shun-Fat Lau, Wei Wu, Daniel Y. K. Wong, Heukjin Seo, Wing-Yu Fu, Nicole C. H. Lai, Yuewen Chen, Yu Chen, Estella P. S. Tong, Vincent C. T. Mok, Timothy C. Y. Kwok, Kin Y. Mok, Maryam Shoai, Benoit Lehallier, Patricia Moran Losada, Eleanor O'Brien, Tenielle Porter, Simon M. Laws, John Hardy, Tony Wyss-Coray, Colin L. Masters, Amy K. Y. Fu, Nancy Y. Ip

Summary: Changes in circulating protein levels are associated with AD, but their specific roles in AD are still unclear. In this study, the researchers identified a new disease-causing factor, soluble ST2 (sST2), and a genetic variant, rs1921622, that downregulates sST2 levels. They found that increased sST2 levels are associated with more severe pathological changes in female individuals with AD, and decreased sST2 levels lower AD risk and related endophenotypes, especially in Chinese populations. Transcriptome and immunohistochemical studies revealed that sST2 regulates Aβ pathology through microglial activation and Aβ clearance.

NATURE AGING (2022)

暂无数据